Medicine recalls
|
| |
| Canada: Recall: M-Eslon (morphine sulfate) ER capsules: One lot recalled as some bottles labelled as M-Eslon 30 mg may contain 60 mg capsules, which may pose an overdose risk |
| |
Health Canada announces that Ethypharm Inc. is recalling one lot of M-Eslon (morphine sulfate) extended release (ER) capsules (lot number: 43885) from retailers because some bottles labelled as M-Eslon 30 mg ER may contain 60 mg capsules. This issue could lead to patients receiving a 60 mg dose instead of their prescribed 30 mg dose, which could result in an overdose and pose serious health risks.
M-Eslon is a prescription opioid drug used by adults for long-term pain management when pain is severe enough to require daily, around-the-clock painkillers and other treatment options are not able to treat the pain.
The 60 mg capsule has "60" and "M-ESLON" printed on it. The capsule has an opaque orange cap and a clear bottom.
The 30 mg capsule has "30" and "M-ESLON" printed on it. The capsule has an opaque pink cap and a clear bottom.
Please refer to the following websites in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/m-eslon-capsule-product-mix
http://recalls-rappels.canada.ca/en/alert-recall/m-eslon-morphine-sulfate-er-capsules-one-lot-recalled-some-bottles-labelled-m-eslon-30
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/ Saturday, Sep 28, 2024
Issued at HKT 12:00
|
| |
